A bright future for lipid nanoparticles in gene therapy

Cell & Gene Therapy Insights 2021; 7(6), 755–758


Published: 9 July 2021
Hongwei Zhang

Hongwei Zhang is Associate Professor and Director of Pharmaceutical Sciences Program at Massachusetts College of Pharmacy and Health Sciences University (MCPHS University) in Boston. The research in Zhang lab is focused on nanomedicine and drug/gene delivery. Dr Zhang received his BS in Pharmacy and PhD in Pharmaceutics from the West China School of Pharmacy at Sichuan University and completed postdoctoral training in the Gene Therapy Center at the University of Massachusetts Medical School. Dr Zhang has published ~70 peer-reviewed journal articles and conference papers in the field of gene delivery and gene therapy. He is the recipient of the Biotechnology Innovation Award from the American Association of Pharmaceutical Scientists. He is the co-inventor of an AAV gene therapy patent.